Skip to main content
Fig. 1 | Journal for ImmunoTherapy of Cancer

Fig. 1

From: Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors

Fig. 1

PD-L1 transcript detection across serial dilutions of 4 tumor samples. PD-L1 transcript detection across serial dilutions of 4 tumor samples. Results demonstrate high, moderate, and low PD-L1 expression and can be reliably quantified by a continuous variable of absolute transcript reads. a Sample 1: Melanoma with high expression. b Sample 2: Melanoma with high expression. c Sample 3: RCC with moderate expression. d Sample 4: RCC with moderate expression

Back to article page